Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone-Reference-Cited by-同舟云学术

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Published:2022-05 Issue:5 Volume:20 Page:1193-1205
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Berkowitz Scott D.^ORCID,Bauersachs Rupert M.^ORCID,Szarek Michael^ORCID,Nehler Mark R.^ORCID,Debus E. Sebastian^ORCID,Patel Manesh R.^ORCID,Anand Sonia S.^ORCID,Capell Warren H.^ORCID,Hess Connie N.^ORCID,Hsia Judy^ORCID,Leeper Nicholas J.^ORCID,Brasil David^ORCID,Mátyás Lajos^ORCID,Diaz Rafael,Brodmann Marianne^ORCID,Muehlhofer Eva^ORCID,Haskell Lloyd P.^ORCID,Bonaca Marc P.^ORCID

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15673

Reference51 articles.

1. Burden of coronary artery disease and peripheral artery disease: a literature review;Bauersachs;Cardiovasc Ther,2019

2. Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P‐TIMI 50;Bonaca;Circulation,2013

3. Acute limb ischemia;Creager;N Engl J Med,2012